Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer

PaperCitations, authors & open-access status

Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 38 citations, 2021 year and closed oa status.

38
Citations
2021
Year
closed
OA Status

Related on ScholarIQ

Takuya Kawahara
Author
Journal of Clinical Oncology
Journal
HER2/EGFR in Cancer Research
Topic
HER2/EGFR in Cancer Research
Topic
Cancer Treatment and Pharmacology
Topic
Breast Cancer Treatment Studies
Topic
470M+ articles · free account